---
title: "NYC VC Fund News: Dimension Capital Files for $750M Fund III at ML × Life Sciences Intersection"
description: "New York-based Dimension Capital filed SEC Form D in June 2026 seeking up to $750M for its third fund, following $350M Fund I and $500M Fund II."
date: 2026-06-08T00:00:00.000Z
tags: ["nyc-vc-news", "fund-close", "new-york-funds", "healthtech", "frontier-tech"]
source: https://venturecapitaltracker.com/nyc-vc-fund-news-2026-06-dimension-capital-750m-fund-iii
---

# NYC VC Fund News: Dimension Capital Files for $750M Fund III at ML × Life Sciences Intersection

> New York-based Dimension Capital filed SEC Form D in June 2026 seeking up to $750M for its third fund, following $350M Fund I and $500M Fund II.

Dimension Capital filed SEC Form D on **June 4, 2026** seeking up to **$750 million** for Fund III — the firm's third vehicle at the intersection of machine learning and life sciences.

## Key facts

- **Firm:** Dimension Capital
- **Date filed:** June 4, 2026
- **Target raise:** Up to $750 million
- **Status:** Fundraising (no capital reported sold at filing)
- **Focus:** ML × life sciences — computation and science frontiers
- **Offices:** 632 Broadway, New York + San Francisco
- **Prior funds:** $350M Fund I (Jan 2023), $500M Fund II (Dec 2024)

## Portfolio highlights

Chai Discovery, NewLimit, Earendil Labs, Odyssey Therapeutics, Aspect Biosystems, Enveda, Congruence Therapeutics, Monte Rosa Therapeutics (Nasdaq-listed).

## Why this matters

Dimension has quickly become one of the leading next-generation life sciences VC firms, and a $750M Fund III would cement NYC as a major hub for computational biology capital deployment. The firm is among the top capital-deployers at the science-compute intersection globally.

## Sources

1. Endpoints News: https://endpoints.news/dimension-seeks-up-to-750m-for-third-life-sciences-fund-after-string-of-success/
2. VCWire (June 8, 2026): https://vcwire.tech/2026/06/08/dimension-capital-raises-up-to-750m-for-third-fund/
3. SEC Form D filing: https://www.sec.gov/Archives/edgar/data/2134488/000101297526000522/0001012975-26-000522-index.htm